London Stock Exchange welcomes SourceBio International plc to AIM

London Stock Exchange today welcomes SourceBio International plc (‘SourceBio’ or the ‘Company’), a leading international provider of integrated state-of-the-art laboratory services and products, to celebrate the listing of the Company's public shares onto AIM, under the ticker "SBI".

SourceBio, employs approximately 235 employees across six sites globally, in the UK, Ireland and the USA with headquarters in Nottingham, UK. The Company provides services and products to clients in the healthcare, clinical, life science research and biopharma industries, with a focus on improving patient diagnosis, management and care. SourceBio operates with four core businesses areas:

•    Healthcare Diagnostics - histopathology and clinical diagnostic services for the NHS and private healthcare across the UK and Ireland;
•    Genomics - DNA sequencing services for pharmaceutical and biotechnology companies, academia, contract research organisations (CROs) and other research groups in the UK, Europe and North America;
•    Stability Storage - shelf life testing services and equipment for pharmaceutical and biotechnology companies, contract manufacturers and analytical testing companies from around the world but primarily in the UK, Ireland and the USA; and
•    Infectious Disease Testing - since May 2020, the Group has provided COVID-19 Antigen RT-PCR testing services. These services passed all of the auditing requirements of the NHS and the Department of Health and Social Care (DHSC) in April 2020. It is intended that this offering will potentially provide a broad range of infectious disease testing across the NHS, private healthcare and commercial sectors in the future.

The Directors believe that the Group is well positioned to capitalise on attractive market opportunities across all of its core business divisions.

The Company has successfully raised £35 million (before expenses) through a placing of new Ordinary Shares, to repay outstanding shareholder and bank loans and for general corporate expenses, including working capital and capital expenditure required in order to further scale-up the COVID-19 testing business. On Admission, the Company will have a market capitalisation of approximately £120m.

Jay LeCoque, Executive Chairman of SourceBio, said: “We are delighted by the strong support we’ve received from new institutional investors and our existing shareholders. Our IPO on AIM allows us to significantly increase our COVID-19 testing capacity, accelerate earnings growth in our core business and execute on potential M&A opportunities. It’s an exciting time for our business and we look forward to executing on our ambitious growth plans and delivering value to our shareholders.”

To find out more about SourceBio visit:  www.sourcebiointernational.com

Quick facts

Track
Market: AIM
Instrument market cap (£m)
114.98
Listing/Admission to trading
29 Oct 2020
Looking for new and recent issues?

More recent

106.12
London Stock Exchange welcomes Ecobank Transnational Incorporated’s debut Sustainable Bond to the Sustainable Bond Market

Ecobank Transnational Incorporated (ETI), the parent company of the Ecobank Group, today opened the market at London Stock Exchange via a virtual ceremony to mark the listing of its $350 million 10NC5 Tier 2 Sustainability Notes issuance.

Through its affiliates across 33 sub-Saharan African countries and its international bank in Paris, Ecobank provides the full suite of banking produ

Learn more
108.6
London Stock Exchange welcomes Victorian Plumbing Group plc to AIM

London Stock Exchange today welcomes Victorian Plumbing Group plc (Group or Company), the UK’s leading online retailer of bathroom products and accessories , to AIM under the ticker “VIC”.
 
Headquartered in Skelmersdale, Lancashire, the Group employs over 500 colleagues across seven locations in Skelmersdale, Manchester and Birmingham.
 
Victorian Plumbing

Learn more
London Stock Exchange welcomes Spectral MD Holdings, Ltd. to AIM

London Stock Exchange today welcomes Spectral MD Holdings, Ltd. (“Spectral MD” of the “Company”) (AIM: SMD) a predictive analytics group that develops proprietary AI algorithms and optical technology for faster treatment decisions in wound care, headquartered in Dallas, Texas, U.S.A. 

Using its DeepView® Wound Imaging Solution, an internally developed AI technology and multispect

Learn more
119.28
London Stock Exchange welcomes Thor Explorations to AIM

London Stock Exchange welcomes Thor Explorations, a West African focussed gold company to AIM under the ticker “THX”. The Company will be trading its common shares and has a market capitalization of circa. £135 million at admission. The listing is supplementary to the Company's listing on the TSX-V in Canada. 

Thor Explorations, which will shortly commence gold production at

Learn more